Drug resistance in children at virological failure in a rural KwaZulu-Natal, South Africa, cohort

AIDS Research and Therapy

Volumn 11, Issue 1, 2014, Pages

  Pillay, Sureshnee ^a   Bland, Ruth M ^a,b   Lessells, Richard J ^a,c   Manasa, Justen ^a   de Oliveira, Tulio ^a,d   Danaviah, Sivapragashini ^a,e  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e DDMRI   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892448987     PISSN: None     EISSN: 17426405     Source Type: Journal    
DOI: 10.1186/1742-6405-11-3     Document Type: Article

References (32)

1. Janssen N, et al. Successful paediatric HIV treatment in rural primary care in Africa. Arch Dis Child 2010, 95(6):414-421. 10.1136/adc.2009.169367, 3181433, 19880392.
2. Meyers T, et al. Changes in pediatric HIV-related hospital admissions and mortality in Soweto, South Africa, 1996-2011: light at the end of the tunnel?. J Acquir Immune Defic Syndr 2012, 60(5):503-510. 10.1097/QAI.0b013e318256b4f8, 3404242, 22487588.
3. Bland RM. Management of HIV-infected children in Africa: progress and challenges. Arch Dis Child 2011, 96(10):911-915. 10.1136/adc.2010.193789, 21562058.
4. Patel SD, et al. Increases in pediatric antiretroviral treatment, South Africa 2005-2010. PLoS One 2012, 7(9):e44914. 10.1371/journal.pone.0044914, 3441457, 23028677.
5. Davies MA, et al. Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaboration. S Afr Med J 2009, 99(10):730-737. 2925142, 20128272.
6. Mofenson LM, Cotton MF. The challenges of success: adolescents with perinatal HIV infection. J Int AIDS Soc 2013, 16:18650. 3687076, 23782484.
7. Gupta RK, Gibb DM, Pillay D. Management of paediatric HIV-1 resistance. Curr Opin Infect Dis 2009, 22(3):256-263. 10.1097/QCO.0b013e3283298f1f, 2735039, 19405216.
8. Sigaloff KC, et al. HIV-1-resistance-associated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review. Lancet Infect Dis 2011, 11(10):769-779. 10.1016/S1473-3099(11)70141-4, 21872531.
9. Meyers T, et al. Challenges to pediatric HIV care and treatment in South Africa. J Infect Dis 2007, 196(Suppl 3):S474-S481.
10. Fatti G, et al. Increased vulnerability of rural children on antiretroviral therapy attending public health facilities in South Africa: a retrospective cohort study. J Int AIDS Soc 2010, 13:46. 10.1186/1758-2652-13-46, 3002304, 21108804.
11. Macdonald P, et al. Paediatric human immunodeficiency virus treatment outcomes from a resource-limited setting in south africa: highly active antiretroviral therapy alone is not enough. Vulnerable Child Youth Stud 2011, 6(3):208-221.
12. Wallis CL, et al. Emergence of drug resistance in HIV-1 subtype C infected children failing the South African National Antiretroviral roll-out program. Paeiatric I nfectious Dis J. 2009, 38(12):1123-1125.
13. Barth RE, et al. Long-term outcome of children receiving antiretroviral treatment in Rural South Africa. Pediatr Infect Dis J 2011, 30(1):52-56. 10.1097/INF.0b013e3181ed2af3, 20631647.
14. van Zyl G, et al. Protease inhibitor resistance in South African children with virologic failure. Pediatr Infect Dis J 2009, 28(12):1125-1127. 10.1097/INF.0b013e3181af829d, 19779394.
15. Pillay V, et al. HIV type 1 subtype C drug resistance among pediatric and adult South African patients failing antiretroviral therapy. AIDS Res Hum Retroviruses 2008, 24(11):1449-1454. 10.1089/aid.2008.0180, 19000027.
16. Taylor BS, et al. Rapid development of antiretroviral drug resistance mutations in HIV-infected children less than Two years of Age initiating protease inhibitor-based therapy in South Africa. AIDS Res Hum Retroviruses 2011, 27(9):945-956. 10.1089/aid.2010.0205, 3161115, 21345162.
17. Green TN, et al. Drug resistance and coreceptor usage in HIV type 1 subtype C-infected children initiating or failing highly active antiretroviral therapy in South Africa. AIDS Res Hum Retroviruses 2012, 28(4):324-332. 10.1089/aid.2011.0106, 3316120, 21819257.
18. Latinovic O, et al. Pharmacotherapy of HIV-1 infection: focus on CCR5 antagonist maraviroc. Clin Med Ther 2009, 1:1497-1510. 2777720, 19920876.
19. Manasa J, et al. High-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural HIV treatment programme in KwaZulu-Natal, South Africa. PLoS One 2013, 0. in press.
20. Osterholzer D. The role of etravirine in the management of treatment-experienced pediatric patients with HIV. HIV AIDS (Auckl) 2013, 5:67-73. 3628526, 23610529.
21. Frange P, et al. Lopinavir/ritonavir-based antiretroviral therapy in human immunodeficiency virus type 1-infected naive children rare protease inhibitor resistance mutations but high lamivudine/emtricitabine resistance at the time of virologic failure. PaedPaediatric Infec Dis J 2011, 30(8):684-688.
22. Orrel C, et al. Resistance in pediatric patients experiencing virologic failure with first- and second-line antiretroviral therapy. Paediatric Infec Dis J 2013, 32(6):644-647.
23. Wallis CL, et al. Low rates of nucleoside reverse transcriptase inhibitor (NRTI) resistance detected in a well monitored cohort in South Africa accessing antiretroviral therapy. Antivir Ther 2012, 17(2):313-320. 3600633, 22293461.
24. Pillay D. Implications of HIV drug resistance on first and second line therapies in resource limited settings :report froma workshop organised by the collaborative HIV and anti-HIV drug resistance network. Antivir Ther 2013, 18(6):831-836. 10.3851/IMP2650, 23740717.
25. Doyon L, et al. Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors. J Virol 1996, 70(6):3763-3769. 190252, 8648711.
26. Houlihan CF, et al. Cohort profile: Hlabisa HIV treatment and care programme. Int J Epidemiol 2011, 40(2):318-326. 10.1093/ije/dyp402, 3195268, 20154009.
27. Cooke GS, et al. Need for timely paediatric HIV treatment within primary health care in rural South Africa. PLoS One 2009, 4(9):e7101. 10.1371/journal.pone.0007101, 2742735, 19771168.
28. de Oliveira T, Shafer RW, Seebregts C. Public database for HIV drug resistance in southern Africa. Nature 2010, 464(7289):673.
29. Libin P, et al. RegaDB: community-driven data management and analysis for infectious diseases. Bioinformatics 2013, 29(11):1477-1480. 10.1093/bioinformatics/btt162, 3661054, 23645815.
30. Alcantara LC, et al. A standardized framework for accurate, high-throughput genotyping of recombinant and non-recombinant viral sequences. Nucleic Acids Res 2009, 37(Web Server issue):W634-W642. 2703899, 19483099.
31. de Oliveira T, et al. An automated genotyping system for analysis of HIV-1 and other microbial sequences. Bioinformatics 2005, 21(19):3797-3800. 10.1093/bioinformatics/bti607, 16076886.
32. Johnson VA, et al. Update of the drug resistance mutations in HIV-1: March 2013. Top Antivir Med 2013, 21(1):6-14.